ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CNC Concurrent Technologies Plc

99.50
-2.00 (-1.97%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Concurrent Technologies Plc LSE:CNC London Ordinary Share GB0002183191 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -1.97% 99.50 98.00 101.00 101.50 99.50 101.50 477,048 16:20:55
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Printed Circuit Boards 18.28M 987k 0.0115 86.52 85.21M

Concurrent Technologies PLC Interim Results (5353A)

26/09/2022 7:01am

UK Regulatory


Concurrent Technologies (LSE:CNC)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Concurrent Technologies Charts.

TIDMCNC

RNS Number : 5353A

Concurrent Technologies PLC

26 September 2022

This announcement contains inside information

Concurrent Technologies PLC

(the "Company")

Interim Results for the six months ended 30 June 2022

Concurrent Technologies PLC (AIM: CNC), a world leading specialist in high-end embedded computer products for critical applications, announces its interim results for the six months to 30 June 2022 ("H1 2022").

Financial Performance

Component supply issues have delayed shipping of some of the Company's products, such that a proportion of expected H1 2022 revenues will be recognised in a later period. However, this is a short-term issue and in no way relates to the quality of the underlying business. Demand for the Company's products is higher than ever with a strong H1 order book (GBP14.2M) and record backlog (GBP20.3M).

-- Revenue of GBP7.4M (H1 2021: GBP9.3M) - reduced solely as a result of components supply issues

   --    Gross profit of GBP3.7M (H1 2021: GBP5.1M) 

-- Gross margin of 50.4% (H1 2021: 54.3%) - reduced as the result of price increases of some components due to high demand and limited supply (-GBP0.3M against H1 revenue)

-- Operating profit of GBP0.1M (H1 2021: GBP1.6M) - predominantly driven by revenue/gross margin variance of -GBP1.4M; net costs increased by cGBP0.2M, in line with investment strategy

   --    Profit before tax of GBP0.0M (H1 2021: GBP1.6M) 
   --    EPS of 0.75 pence (H1 2021: 2.09 pence) 
   --    Interim dividend suspended for H1 2022 (H1 2021: 1.15 pence per share) 

-- Cash Balance (including cash deposits) as at 30 June 2022 of GBP9.3M (31(st) Dec 2021: GBP11.8M)

o reduced due to lower cashflow from operations of GBP0.6M, and continued investment of GBP3M, in line with our strategy

o R&D investment will continue into H2 2022 at a similar level as H1 2022

Operational Summary

-- Strong order intake of GBP14.2M as at 30 June 2022, with significant backlog of GBP20.3M compared to GBP15.6M backlog as at 30 June 2021, up 30%

   --    Defence is largest market sector at 76% revenue 
   --    Global customer base is solid with exports generating 90% of revenue 

-- R&D costs (talent, improved process & analysis, materials) have increased by 50% to GBP2.4M (H1 2021 GBP1.6M), in line with stated strategy to enhance the number of product releases per annum and reflect the more complex nature of our offerings

-- Three new products launched in H1 2022 and on track to launch eight new products during FY2022 (approx. double previous cadence)

-- Component shortages have been exceptionally challenging, causing a significant limitation to our ability to ship product

-- Major new order with a Fortune 500 medical company with a $2.3M purchase order in 2022 and similar sized orders anticipated for several years to come

   --    Experienced leadership team fully in place 
   --    New office opened in Theale to attract and retain talent 

-- 20% increase in headcount, in line with strategy, to enhance new product delivery and support our path to growth

Miles Adcock, CEO of Concurrent Technologies, commented : "Short term component availability is resulting in constrained performance in FY2022, with limited visibility of exactly when it will ease. However, order intake is strong, and would otherwise reflect in a solid improvement in revenues. Order intake should strengthen further as strategic initiatives take effect in FY2023 and beyond. Post period end, total order intake has further strengthened to GBP20.8M, producing a current backlog of GBP24.2M as at 12 September 2022. After more than a full year now leading this business, I am even more confident in our ability to grow and develop a successful global enterprise."

CHAIRMAN'S STATEMENT

Whilst it is clearly disappointing the component supply issue has impacted on our revenues and profitability in the first half of 2022, which will continue in the second half of the year, it is important not to lose sight of the improving underlying fundamentals of the business, demonstrated in our product development, new customers, order intake, backlog and management strength. The component supply issues will ease and, although we can't be sure exactly when, when they do we are well positioned to benefit from all the underlying fundamentals highlighted, which will drive long term growth.

The cash position of the Company remains strong, which has allowed us to continue to invest in engineering and product development. The long term success of any technology company is bringing innovative new products to market first and that is, and will remain, our focus.

Given the strong balance sheet, paying an interim dividend out of historical retained earnings was considered. However, paying dividends from current year earnings is an important discipline we wish to maintain. We are committed to paying a dividend and our shareholders will see the benefit of this as we drive growth in the coming years .

CHIEF EXECUTIVE'S REVIEW

Financial Summary

The Company has continued to operate in a very challenging environment in H1 2022. The global component shortage impacts the entire electronics sector and has had a significant impact on short term performance. The delay in completing the full manufacture of certain products, and a consequent delay in their shipping, has resulted in deferred invoicing and a corresponding reduction in revenue in the period against the prior year by 20% to GBP7.4M (H1 2021: GBP9.3M).

It is important to note that the impacted revenue is delayed and not lost, and we continue to recognise an exceptional backlog. We have strong relationships with our customers and are driving the pace for delivery. It is recognised by the customer base that the issues are driven by external factors (which all our competitors are also facing).

Demand driven increase in the costs of some components has also resulted in a reduction in gross margin of c.7% from 54.3% to 50.4%. Both revenue and gross margin impacts are solely driven by component shortages and are not a reflection of the quality of our underlying business. We have delivered an unaudited profit before tax (PBT) of GBP0.0M (H1 2021: GBP1.6M), a net variance of -GBP1.6M, primarily caused by the reduction in revenue volume and gross margin, with underlying net costs having increased by GBP0.2M (as per strategy, this is predominantly driven by investment in talent).

The balance sheet remains strong with no debt and GBP9.3M of cash balances (including cash deposits) as at 30 June 2022 (31 December 2021: GBP11.8M). In response to the components shortage, there has been a substantial and carefully managed investment in additional inventory, with an increase of GBP2.8M, to GBP9.4M (H1 2021: GBP6.6M). As the global supply chain recovers, and components become available, revenue generation will accelerate as the business not only delivers normal run rate outputs, but also increases capacity to enable the processing of the now record backlog (GBP20.3M at 30(th) June 2022 compared to GBP15.6M at 30 June 2021). Whilst the backlog is to some degree inflated due to the challenges of supply, it is important to note that FY2021 order intake was at a record level (GBP25.2M), and an order intake of GBP14.2M in H1 2022 puts the business on track to secure another very strong year of customer commitment.

Review of Operations

Despite the headwind generated by short term components shortages, the business is making good progress with operational improvement and implementation of the strategy.

A refreshed leadership team is now complete, with the new CFO Kim Garrod, being the most recent joiner in May 2022. We have also recruited additional talent across the organisation in engineering and sales, as well as fully implementing new functions such as HR and Legal/Commercial, growing our headcount from 99 to 118 in the last 12 months.

We have previously stated that it is imperative that we deliver more products to market in a timelier fashion. Having set the challenge of broadly doubling our cadence of new product releases to eight this year, we have indeed released three new products in the first half of 2022 and remain on track to achieve the objective of eight for the full year. This is reflected in a 100% increase in the cost of capitalised R&D compared to H1 2021.

We said we would develop a Build to Print partner in the USA to better access that domestic market. We have now qualified Nextek, based in Madison, Alabama. The intent is to be able to offer to the market genuinely 'Assembled in the USA' products by the end of 2022.

In addition to designing and manufacturing single board computers, we committed to invest in developing a systems business. Having recruited specialist experts during H1, and engaging in business development dialogue with potential partners and customers, we will secure initial contracts with new customers in H2 2022. An example of another new customer relationship that we have developed is the $2.3M purchase order from a Fortune 500 medical sector business, with the opportunity for similar size purchase orders from the same customer for several years to come.

Current Trading & Outlook

With a record H1 backlog of GBP20.3M, and a record YTD Order In-take of GBP20.8M (as at 12 September 2022), the business is starting to benefit from the refreshed approach to operations and strategy. We have transformed from primarily relying on end of life products in recent years, to four fifths of our orders this year being for our current and new products, which are exciting existing and new customers. In addition to increased demand from the market, we have built increased capacity to deliver through additional shifts and a qualified build to print partner in the United States. Whilst the challenge of securing semiconductor components is frustratingly constraining everyone's ability to ship completed product, we are well positioned for material growth as the situation resolves.

 
 Condensed Consolidated Statement of Comprehensive Income 
                                    Unaudited interim results to 30th June 2022 
                                                            Six months           Six months                 Year 
                                                                 ended                ended                ended 
                                             Note             30/06/22             30/06/21             31/12/21 
 CONTINUING OPERATIONS                                             GBP                  GBP                  GBP 
 Revenue                                               7,421,285            9,315,839          20,450,453 
 Cost of sales                                         3,680,258            4,255,669            9,016,878 
 Gross profit                                          3,741,027            5,060,170          11,433,575 
 Net operating expenses                                3,688,676            3,439,699            7,889,921 
 Group operating profit                                     52,351          1,620,471            3,543,654 
 Interest Costs                                           (26,930)             (32,233)             (61,679) 
 Finance income                                              6,992                3,696                1,880 
 Other Income                                                      -                    -                    - 
 Profit before tax                                          32,413          1,591,934            3,483,855 
 Tax                                                    (518,890)                56,559             638,412 
 Profit for the period                                    551,303           1,535,375            2,845,443 
                                                   ===================  ===================  =================== 
 
 Other Comprehensive Income 
 Exchange differences on translating foreign 
  operations                                              100,789              (19,626)               23,894 
 Tax relating to components of other                                 -                    -                    - 
 comprehensive 
 income 
 Other Comprehensive Income for the period, 
  net of tax                                              100,789              (19,626)               23,894 
 Total Comprehensive Income for the 
  period                                                  652,092           1,515,749            2,869,337 
                                                   ===================  ===================  =================== 
 
 Profit for the period attributable 
  to: 
 Equity holders of the parent                             551,303           1,535,375            2,845,443 
                                                   -------------------  -------------------  ------------------- 
 
 Total Comprehensive Income attributable 
  to: 
 Equity holders of the parent                             652,092           1,515,749            2,869,337 
                                                   -------------------  -------------------  ------------------- 
 
 Earnings per share 
 Basic earnings per share                       4                0.75p                2.09p                3.88p 
 
 Diluted earnings per share                     4                0.75p                2.09p                3.88p 
 
 Adjusted earnings per share                                     0.75p                2.09p                3.72p 
 
 
                           CONDENSED CONSOLIDATED BALANCE SHEET 
                        Unaudited interim results to 30th June 2022 
                                         As at              As at              As at 
                                        30/06/22           30/06/21           31/12/21 
 ASSETS                                   GBP                GBP                GBP 
 Non-current assets 
 Property, plant and equipment         2,445,996          1,735,125          1,436,009 
 Intangible assets                     9,058,713          7,333,105          7,692,528 
 Deferred tax assets                         7,243             88,455             31,042 
 Other Financial Assets                            -                  -                  - 
                                     11,511,952           9,156,685          9,159,579 
 Current assets 
 Inventories                           9,460,432          6,619,081          6,425,436 
 Trade and other receivables           3,460,344          2,614,711          2,988,633 
 Current tax assets                       597,086            351,104            330,748 
 Other Financial Assets                            -                  -                  - 
 Cash and cash equivalents             9,265,663        12,386,445         11,839,758 
                                     22,783,525         21,971,341         21,584,575 
 
 Total assets                        34,295,476         31,128,026         30,744,154 
                                   -----------------  -----------------  ----------------- 
 
 LIABILITIES 
 Non-current liabilities 
 Deferred tax liabilities              2,176,884          1,638,947          2,193,418 
 Trade and other payables (LT 
  Lease)                                  505,767            518,919            570,576 
 Long term provisions                       18,256             18,256             19,172 
                                       2,700,907          2,176,122          2,783,166 
 Current liabilities 
 Trade and other payables              7,119,058          5,625,215          4,196,272 
 Short term provisions                      18,256             18,256             19,300 
 Current tax liabilities                    15,779             33,190              4,817 
                                       7,153,093          5,676,661          4,220,389 
 
 Total liabilities                     9,854,000          7,852,783          7,003,555 
                                   -----------------  -----------------  ----------------- 
 
 Net assets                          24,441,476         23,275,243         23,740,599 
                                   =================  =================  ================= 
 
 EQUITY 
 Capital and reserves 
 Share capital                            739,000            739,000            739,000 
 Share premium account                 3,699,105          3,699,105          3,699,105 
 Capital redemption reserve               256,976            256,976            256,976 
 Cumulative translation reserve              3,390         (140,919)            (97,399) 
 Profit and loss account             19,743,006         18,721,081         19,142,917 
 Equity attributable to equity 
  holders of the parent              24,441,477         23,275,243         23,740,599 
 
 Total equity                        24,441,477         23,275,243         23,740,599 
                                   =================  =================  ================= 
 
 
                                   Condensed Consolidated Cash Flow Statement 
                                   Unaudited interim results to 30th June 2022 
                                                              Six months          Six months                  Year 
                                                                   ended               ended                 ended 
                                                              30/06/2022          30/06/2021            31/12/2021 
                                                                     GBP                 GBP                   GBP 
 Cash flows from operating activities 
 Profit before tax for the period                               32,413         1,591,934           3,483,855 
 Adjustments for: 
   Finance income                                               (6,992)             (3,696)             (1,880) 
   Finance costs                                                26,930              32,233              61,679 
   Depreciation                                               121,589               84,757            288,560 
   Amortisation                                               627,395             606,453          1,234,655 
   Impairment loss                                                     -          150,000             570,812 
   Loss on disposal of property, plant and equipment 
    (PPE)                                                              -            28,778              27,401 
   Share-based payment                                          48,785              16,339              12,963 
   Exchange differences                                       111,153             (16,762)              46,623 
   (Increase)/decrease in inventories                     (3,034,996)         (1,085,507)           (891,862) 
   (Increase)/decrease in trade and other receivables       (471,711)           (258,554)           (632,476) 
   Increase/(decrease) in trade and other payables         2,920,826           1,645,319              330,735 
 Cash generated from operations                               375,392          2,791,294           4,531,065 
 Tax (paid)/received                                          270,780             (21,110)            (40,274) 
 Net cash generated from operating activities                 646,172          2,770,184           4,490,791 
                                                       =================   =================   =================== 
 
 Cash flows from investing activities 
 Interest received                                               6,992               3,696               1,880 
 Cash placed on deposit                                                -                   -                   - 
 Purchases of property, plant and equipment (PPE)         (1,124,354)           (115,045)           (185,879) 
 Proceeds from sale of PPE                                             -                   -             1,500 
 Purchases of intangible assets                           (1,993,577)           (883,983)         (2,124,529) 
 Net cash used in investing activities                    (3,110,939)           (995,332)         (2,307,028) 
 
 Cash flows from financing activities 
 Equity dividends paid                                                 -      (1,063,769)         (1,907,447) 
 Repayment of leasing liabilities                             (64,809)            (56,871)          (117,613) 
 Interest paid                                                (26,930)            (32,233)            (61,679) 
 Cash received from share issue                                        -                   -                   - 
 Purchase of treasury shares                                           -                   -                   - 
 Net cash used in financing activities                        (91,739)        (1,152,873)         (2,086,739) 
 
 Effects of exchange rate changes on cash and cash 
  equivalents                                                 (17,589)              (1,508)           (23,240) 
 
 Net increase/(decrease) in cash                          (2,574,095)             620,471               73,784 
 Cash at beginning of period                             11,839,758          11,765,974          11,765,974 
 Cash at the end of the period                             9,265,663         12,386,445          11,839,758 
                                                       =================   =================   =================== 
 
 
 
 
 
 
                                        CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY 
                                            Unaudited interim results to 30th June 2022 
                                                                 Capital         Cumulative              Profit 
                             Share              Share         redemption        translation            and loss               Total 
                           capital            premium            reserve            reserve             account              Equity 
                               GBP                GBP                GBP                GBP                 GBP                 GBP 
 Balance at 1 
  January 2021          739,000         3,699,105             256,976          (121,293)       18,271,819          22,845,607 
 
 Profit for the 
  period                         -                  -                  -                  -      1,535,375           1,535,375 
 Exchange 
  differences 
  on 
  translating 
  foreign 
  operations                     -                  -                  -         (19,626)                    -          (19,626) 
 Total 
  recognised 
  comprehensive 
  income for 
  the 
  period                         -                  -                  -         (19,626)        1,535,375           1,515,749 
 Share-based 
  payment                        -                  -                  -                  -           16,339              16,339 
 Deferred tax 
  on 
  share based 
  payment                        -                  -                  -                  -         (38,683)            (38,683) 
 Dividends paid                  -                  -                  -                  -     (1,063,769)         (1,063,769) 
 Sale of 
 treasury 
 shares                          -                  -                  -                  -                  -                   - 
 Issue of 
 Ordinary 
 shares                          -                  -                  -                  -                  -                   - 
 Balance at 30 
  June 2021             739,000         3,699,105             256,976          (140,919)       18,721,081          23,275,243 
                 =================  =================  =================  =================  ==================  ================== 
 
 Total 
  recognised 
  comprehensive 
  income for 
  the 
  period                         -                  -                  -                  -      1,310,059           1,310,059 
 Exchange 
  differences 
  on 
  translating 
  foreign 
  operations                     -                  -                  -           43,520                    -            43,520 
                                                                                             ------------------  ------------------ 
 Total 
  recognised 
  comprehensive 
  income for 
  the 
  period                         -                  -                  -           43,520        1,310,059           1,353,579 
 Share-based 
  payment                        -                  -                  -                  -           (3,376)             (3,376) 
 Deferred tax 
  on 
  share based 
  payment                        -                  -                  -                  -         (41,169)            (41,169) 
 Dividends paid                  -                  -                  -                  -       (843,678)           (843,678) 
 Sale of 
 treasury 
 shares                          -                  -                  -                  -                  -                   - 
                 -----------------  -----------------                     -----------------  ------------------  ------------------ 
 Balance at 31 
  December 2021         739,000         3,699,105             256,976            (97,399)      19,142,917          23,740,599 
                 =================  =================  =================  =================  ==================  ================== 
 
 Total 
  recognised 
  comprehensive 
  income for 
  the 
  period                         -                  -                  -                  -         551,303             551,303 
 Exchange 
  differences 
  on 
  translating 
  foreign 
  operations                     -                  -                  -         100,789                     -          100,789 
                 -----------------  -----------------  -----------------  -----------------  ------------------  ------------------ 
 Total 
  recognised 
  comprehensive 
  income for 
  the 
  period                         -                  -                  -         100,789            551,303             652,092 
 Share-based 
  payment                        -                  -                  -                  -           48,785              48,785 
 Deferred tax 
  on 
  share based 
  payment                        -                  -                  -                  -                   1                   1 
 Dividends paid                  -                  -                  -                  -                  -                   - 
 Issue of 
 ordinary 
 shares                          -                  -                  -                  -                  -                   - 
 Sale of 
 treasury 
 shares                          -                  -                  -                  -                  -                   - 
                 -----------------  -----------------  -----------------  -----------------  ------------------  ------------------ 
 Balance at 30 
  June 2022             739,000         3,699,105             256,976               3,390      19,743,006          24,441,477 
                 =================  =================  =================  =================  ==================  ================== 
 

NOTES TO THE INTERIM REPORT

   1.    General information 

The principal activity of the Group is design, manufacture and supply of innovative high-end embedded single board computers and complementary accessories aimed at a wide base of customers within the defence & aerospace, telecommunications, medical and other markets.

Concurrent Technologies PLC ("the Company") is the Group's ultimate parent company. It is incorporated and domiciled in Great Britain. Concurrent Technologioes PLC shares are listed on the Alternative Investment Market of the London Stock Exchange.

The Group's condensed consolidated interim financial statements are presented in pounds sterling (GBP), which is also the functional currency of the parent company.

These condensed consolidated interim financial statements, which are unaudited, have been approved for issue by the Board of Directors on 23(rd) September 2022.

The information relating to the six months ended 30(th) June 2022 is unaudited and does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006. The statutory accounts for the year ended 31(st) December 2021, prepared in accordance with IFRSs (International Financial Reporting Standards) as adopted by the European Union, have been reported on by the Group's auditors and delivered to the Registrar of Companies. The auditor's report was qualified, and this qualification will be addressed in the statutory accounts for 31(st) December 2022.

   2.    Summary of significant accounting policies 

2.1 Basis of preparation

These condensed consolidated interim financial statements are for the six months period ended 30(th) June 2022. They have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all of the information required for full annual financial statements and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31(st) December 2021, which have been been prepared in accordance with adopted IFRSs.

The accounting policies applied and methods of computation are consistent with those of the annual financial statements for the year end 31(st) December 2021, as described in those financial statements. The accounting policies have been consistently applied to all the periods presented.

There are no new IFRSs or IFRIC interpretations that are effective for the first time for the financial period beginning on or after 1(st) January 2022 that would be expected to have a material impact on the results or financial position of the Group.

2.2 Going Concern

The Directors are satisfied that the Group has sufficient resources to continue in operation for the foreseeable future, a period of not less than 12 months from the date of this report. Accordingly the continue to adopt the going concern basis in preparing these condensed financial statements.

2.3 Taxation

Current tax expense is recognised in these condensed consolidated interim financial statements based on the estimated effective tax rates for the full year.

   3.    Segmental reporting 

The Directors consider that the Group is engaged in a single segment of business, being design, manufacture of high-end embedded computer products and that therefore, the Company has only a single operating segment. The key measure of performance used by the Board to assess the Group's performance is the Group's profit before tax, as calculated under IFRS, and therefore no reconciliation is required between the measure of profit or loss used by the Board and that contained in the condensed consolidated interim financial statements.

   4.    Earnings per share 

Basic earnings per share is calculated by dividing the profit attributable to ordinary equity holders for the period by the weighted average number of ordinary shares outstanding during the period.

Diluted earnings per share is calculated adjusting the weightesd average number of ordinary shares outstanding to assume conversion of all contracted dilutive potential ordinary shares. The Company only has one category of dilutive potential ordinary shares, namely share options.

The inputs to earnings per share calculation are shown below:

 
                                                               Six            Six           Year 
                                                            months         months 
                                                             ended          ended          ended 
                                                          30/06/22       30/06/21       31/12/21 
                                                               GBP            GBP            GBP 
 Profit attributable to ordinary 
  equity holders                                      551,303           1,535,375      2,845,443 
 
                                                               Six            Six           Year 
                                                            months         months 
                                                             ended          ended          ended 
                                                          30/06/22       30/06/21       31/12/21 
                                                              Ndeg           Ndeg           Ndeg 
 
 Weighted average number of ordinary 
  shares for basic earnings per share            73,363,490           73,673,490     73,363,490 
 Adjustment for share                                            - 
 options 
 Weighted average number of ordinary 
  shares for diluted earnings per share          73,363,490           73,673,490     73,363,490 
                                               ===================  =============  ============= 
 
   5.    Shareholder Communication 

A copy of these condensed interim financial statements is available from the Company's Registered office at:

4 Gilberd Court,

Newcomen Way,

Colchester,

Essex, UK

CO4 9WN

They are also available from the Company's website at www.gocct.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IR UVSORUUUKUAR

(END) Dow Jones Newswires

September 26, 2022 02:01 ET (06:01 GMT)

1 Year Concurrent Technologies Chart

1 Year Concurrent Technologies Chart

1 Month Concurrent Technologies Chart

1 Month Concurrent Technologies Chart

Your Recent History

Delayed Upgrade Clock